HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement Sector Regulatory Milestones: Senators' Enforcement Push, GNC Supply Chain Guidelines

This article was originally published in The Rose Sheet

Executive Summary

Former FDA OCI Director George Karavetsos says GNC's supply chain guidelines for its vendors is the industry standard, while Sens. Hatch and Heinrich exceeded all standards by recommending DoJ get tougher on firms violating FDA supplement product regulations,

You may also be interested in...



USPlabs' DMAA Supplement Source Convicted In Separate Criminal Case

Federal prosecutors already have cooperation in their case against USPlabs from GNC in exchange for a "non-prosecution" commitment, and might seek help from an executive with S.K. Labs recently convicted on five criminal counts stemming from a separate investigation.

GNC Supply Chain Reform Pays Dividends In DoJ Settlement From DMAA Investigation

DoJ announces a "non-prosecution agreement" that requires GNC to pay $2.25m and to cooperate in dietary supplement market investigations conducted by FDA and other federal agencies, including the current litigation against USPlabs.

GNC Looks To Boost Trust With Supply Guidelines, Margins With More Franchises

After spearheading the start of a coalition to improve the industry's image, GNC develops guidelines on tracking ingredients from cultivation to harvest and through to processing, storage, transportation and testing. It also plans a significant increase in the number of its stores that franchisees operate.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS109237

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel